Stock Purchase and Award Plans , ESPP, Valuation Assumptions and Compensation Expense (Details) (USD $)
In Millions, except Per Share data, unless otherwise specified |
12 Months Ended | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 26, 2013
|
Apr. 27, 2012
|
Apr. 29, 2011
|
||||||||||||
Fair Value Assumptions Used in Black-Scholes Model | ||||||||||||||
Weighted average fair value of options granted (per share) | $ 7.42 | $ 6.88 | $ 8.19 | |||||||||||
Expected life (years) | 6 years 6 months | [1] | 6 years 4 months 24 days | [1] | 6 years 3 months 18 days | [1] | ||||||||
Risk-free interest rate | 0.94% | [2] | 1.82% | [2] | 2.25% | [2] | ||||||||
Volatility | 26.22% | [3] | 25.97% | [3] | 26.03% | [3] | ||||||||
Dividend yield | 2.64% | [4] | 2.78% | [4] | 2.40% | [4] | ||||||||
Stock-based Compensation Expense by Plan | ||||||||||||||
Stock-based compensation expense | $ 152 | $ 161 | $ 198 | |||||||||||
Income tax benefits | (43) | (45) | (58) | |||||||||||
Stock-based compensation expense, net of tax | 109 | 116 | 140 | |||||||||||
Cost of Products Sold
|
||||||||||||||
Stock-based Compensation Expense by Plan | ||||||||||||||
Stock-based compensation expense | 12 | 12 | 22 | |||||||||||
Research and Development Expense
|
||||||||||||||
Stock-based Compensation Expense by Plan | ||||||||||||||
Stock-based compensation expense | 31 | 29 | 49 | |||||||||||
Selling, General and Administrative Expense
|
||||||||||||||
Stock-based Compensation Expense by Plan | ||||||||||||||
Stock-based compensation expense | 109 | 118 | 127 | |||||||||||
Physio-Control Divestiture-related Costs
|
||||||||||||||
Stock-based Compensation Expense by Plan | ||||||||||||||
Stock-based compensation expense | 0 | 2 | 0 | |||||||||||
Stock Options
|
||||||||||||||
Share-based Payments | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | 10 years | |||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 4 years | |||||||||||||
Stock-based Compensation Expense by Plan | ||||||||||||||
Stock-based compensation expense | 44 | 60 | 87 | |||||||||||
Restricted Stock Awards
|
||||||||||||||
Share-based Payments | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 4 years | |||||||||||||
Stock-based Compensation Expense by Plan | ||||||||||||||
Stock-based compensation expense | 96 | 86 | 97 | |||||||||||
Performance-Based Restricted Stock Award
|
||||||||||||||
Share-based Payments | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 3 years | |||||||||||||
Employee Stock Purchase Plan
|
||||||||||||||
Employee Stock Purchase Plan | ||||||||||||||
Maximum employee contribution rate | 10.00% | |||||||||||||
Purchase price of common stock as a percentage of its fair market value | 85.00% | |||||||||||||
Shares purchased by employees (in shares) | 2 | |||||||||||||
Average purchase price | $ 36.11 | |||||||||||||
Amount withheld to purchase common stock | 6 | |||||||||||||
Shares available for future purchase (in shares) | 8 | |||||||||||||
The discount rate from market value on purchase date | 15.00% | |||||||||||||
Stock-based Compensation Expense by Plan | ||||||||||||||
Stock-based compensation expense | 12 | 13 | 14 | |||||||||||
Physio-Control Award Acceleration
|
||||||||||||||
Stock-based Compensation Expense by Plan | ||||||||||||||
Stock-based compensation expense | $ 0 | $ 2 | $ 0 | |||||||||||
2008 Plan
|
||||||||||||||
Share-based Payments | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | 29 | |||||||||||||
|